(Q40314768)

19 September 2017

title

Insulin-like growth factor-I stimulates H4II rat hepatoma cell proliferation: dominant role of PI-3'K/Akt signaling (English)

1 reference

19 September 2017

main subject

hepatocellular carcinoma

1 reference

Catherine Alexia

1

1 reference

19 September 2017

Pascal Fourmatgeat

series ordinal

2

1 reference

19 September 2017

Danièle Delautier

series ordinal

3

1 reference

19 September 2017

André Groyer

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

17 February 2006

1 reference

Experimental Cell Research

19 September 2017

published in

1 reference

19 September 2017

volume

312

1 reference

19 September 2017

issue

7

1 reference

19 September 2017

page(s)

1142-1152

1 reference

Pathogenesis of hepatocellular carcinoma

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Dysregulation of apoptosis in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Hepatocyte death in hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin-like growth factors I and II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Oncogenes and the strategy of growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin-like growth factors and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Molecular and cellular aspects of the insulin-like growth factor I receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Differential expression of transforming growth factor a and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Cloning and increased expression of an insulin receptor substrate - 1-like gene in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Expression and regulation of the insulin-like growth factor-1 receptor by growing and quiescent H4IIE hepatoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

A simple, rapid, and sensitive DNA assay procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Genetics of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Identification of Rat Cell Lines that Preferentially Express Insulin-Like Growth Factor Binding Proteins rlGFBP-1, 2, or 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Cell cycle and death control: long live Forkheads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Phosphorylation and regulation of Raf by Akt (protein kinase B)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Regulation of Raf-Akt Cross-talk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Studies of the mitogen-activated protein kinases and phosphatidylinositol-3 kinase in the lens. 2. The intercommunications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Inhibition of phosphatidylinositol-3-kinase enhances insulin stimulation of insulin receptor substrate 1 tyrosine phosphorylation and extracellular signal-regulated kinases in mouse R- fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Rapid activation of protein kinase B/Akt has a key role in antiapoptotic signaling during liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

PTEN/MMAC1 mutations in hepatocellular carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.01.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2006.01.007

1 reference

19 September 2017

1 reference